Laetitia Furio Selected Research

Genetic Skin Diseases

5/2014	Intercellular skin barrier lipid composition and organization in Netherton syndrome patients.
3/2014	Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laetitia Furio Research Topics

Disease

7	Netherton Syndrome 01/2015 - 11/2011
4	Skin Diseases (Skin Disease) 01/2015 - 03/2012
3	Inflammation (Inflammations) 01/2016 - 09/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2015 - 01/2013
2	Muscle Cramp (Cramp) 08/2015 - 01/2013
2	Hypersensitivity (Allergy) 09/2014 - 10/2012
2	Genetic Skin Diseases 05/2014 - 03/2014
2	Atopic Dermatitis (Atopic Eczema) 03/2014 - 10/2012
1	Ciliopathies 01/2022
1	Infections 01/2016
1	Exfoliative Dermatitis (Erythroderma) 03/2014

Drug/Important Bio-Agent (IBA)

5	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 11/2011
5	Kallikreins (Kallikrein)IBA 01/2015 - 01/2013
3	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2013 - 03/2012
2	CathelicidinsIBA 08/2015 - 01/2013
2	Antimicrobial PeptidesIBA 08/2015 - 01/2013
2	Insulin (Novolin)FDA Link 08/2015 - 01/2013
2	Serine Peptidase Inhibitor Kazal-Type 5IBA 05/2014 - 03/2012
1	Dinoprostone (PGE2)FDA Link 01/2022
1	CalpainIBA 01/2016
1	Volatile Fatty AcidsIBA 08/2015
1	matriptaseIBA 01/2015
1	EnzymesIBA 06/2014
1	LipidsIBA 05/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2014
1	1,2,4-triazoleIBA 08/2013
1	Serine Proteases (Serine Protease)IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	InterferonsIBA 01/2013
1	LigandsIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	TrypsinIBA 01/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013

Therapy/Procedure

1	Therapeutics 03/2014